Alexandre Michaux
Overview
Explore the profile of Alexandre Michaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michaux A, Mauen S, Breman E, Dheur M, Twyffels L, Saerens L, et al.
J Immunother
. 2022 Feb;
45(3):150-161.
PMID: 35191428
Allogeneic chimeric antigen receptor (CAR) T holds the promise of taking this therapeutic approach to broader patient populations while avoiding the intensive manufacturing demands of autologous cell products. One limitation...
2.
Vigneron N, Stroobant V, Ma W, Michaux A, Van den Eynde B
Methods Mol Biol
. 2019 Jun;
1988:159-186.
PMID: 31147940
Identification of antigenic peptides recognized by cytolytic T lymphocytes (CTL) is a prerequisite for the development of targeted cancer immunotherapy approaches. This chapter provides a global approach for the identification...
3.
Breman E, Demoulin B, Agaugue S, Mauen S, Michaux A, Springuel L, et al.
Front Immunol
. 2019 Jan;
9:2940.
PMID: 30619300
Chimeric Antigen Receptor (CAR) T cells expressing the fusion of the NKG2D protein with CD3ζ (NKG2D-CAR T Cells) acquire a specificity for stress-induced ligands expressed on hematological and solid cancers....
4.
Michaux A, Larrieu P, Stroobant V, Fonteneau J, Jotereau F, Van den Eynde B, et al.
J Immunol
. 2014 Jan;
192(4):1962-71.
PMID: 24453253
Peptide splicing is a novel mechanism of production of peptides relying on the proteasome and involving the linkage of fragments originally distant in the parental protein. Peptides produced by splicing...
5.
Vigneron N, Ma W, Michaux A, Van den Eynde B
Methods Mol Biol
. 2013 Jan;
960:187-207.
PMID: 23329489
Identification of antigenic peptides recognized by cytolytic T lymphocytes (CTL) is a prerequisite for the development of targeted cancer immunotherapy approaches. This chapter provides a global approach for the identification...
6.
Stroobant V, Demotte N, Luiten R, Leonhardt R, Cresswell P, Bonehill A, et al.
Eur J Immunol
. 2012 Jun;
42(6):1417-28.
PMID: 22678898
Antitumor cytolytic T lymphocytes (CTLs) recognize peptides derived from cellular proteins and presented on MHC class I. One category of peptides recognized by these CTLs is derived from proteins encoded...